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Acute lymphoblastic leukemia (ALL) predominates in children ages 0-14 years and has 
an excellent prognosis for cure with 5-year survival exceeding 90% in the United States. 
However, not all children experience such positive outcomes. The purpose of this 
quantitative, retrospective cohort study was to evaluate differences in survival of ALL 
among children who reside in the 32-county Texas-Mexico border region. While factors 
such as poverty and health insurance have been strongly associated with poorer cancer 
outcomes, additional factors such as geographic isolation and treatment disparities are not 
as well-documented in children. This study examined the association between use of 
Texas Children’s Oncology Group (COG) pediatric research facilities and survival 
among children in Texas diagnosed with ALL. This study used cancer incidence data 
1995-2009 from the Texas Cancer Registry. Differences in survival and use of COG 
facilities were investigated between children who reside within the 32-county Texas-
Mexico border region and the combined remaining 222 Texas counties. Chi-square was 
used to analyze area of residence, gender, race/ethnicity, and poverty status between 
COG and non-COG reported cases. Logistic regression was used to examine ALL 
survival differences between COG and non-COG facilities controlling for multiple 
variables. COG affiliation alone was not a significant predictor of survival. An interaction 
between race/ethnicity, region, poverty status, and COG facility affiliation was observed 
as a significant predictor of poorer survival. The results of this study have the potential to 
promote positive social change by implementing interventions addressing access to 
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Chapter 1: Introduction to the Study 
Introduction 
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer in the 
United States, accounting for about one-quarter of all malignancies diagnosed in children 
0-14 years of age (Hunger et al., 2012).  Using the latest statistics from the American 
Cancer Society (2016), approximately 3,000 children between the ages 0-14 years will be 
diagnosed with ALL in the United States in 2016. Most of those children will be between 
the ages of 2 and 5 years at the time of diagnosis (Robison, 2011). 
 The successful treatment of children diagnosed with ALL is considered one of 
modern medicine’s greatest success stories against cancer, with current overall 5-year 
survival rates of over 85% in developed countries (Pui, Mullighan, Evans, & Relling, 
2012). Why 15% percent of children with ALL have poorer outcomes remains under 
robust investigation. Such studies have revealed both clinical and demographic factors to 
be involved in both short and long-term survival of the disease (Bhatia, 2011).  
 Acute leukemia is thus named as the disease progresses rapidly. The best 
outcomes are marked by not only initial expedient intervention, but treatment targeted to 
the patient’s specific disease metrics. The most advanced therapies for ALL are based on 
several personal and biological metrics to assess the disease in a particular individual and 
determine the best course of proven treatment. This risk-based treatment strategy requires 
advanced technology testing, complex chemotherapy treatment, expert specialty care, 
multiple visits, and long-term followup care. Specialized pediatric oncology research 
centers that offer such protocols are members of the Children's Oncology Group (COG). 
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Children diagnosed with ALL treated at these facilities experience survival approaching 
95% (Pui, Pei, et al., 2012). In this study I examined the extent of COG facility 
participation of children diagnosed with ALL in Texas. The purpose of this study was to 
determine if facilities in Texas that have achieved COG membership offer prognostic 
significance in pediatric ALL survival, and identify possible underserved areas for 
positive interventions. This chapter describes key factors and issues related to the study. 
Background of the Study 
Texas is currently home to 15 pediatric oncology research centers that have been 
designated COG institutions (COG, 2015). This organization is the world’s largest 
pediatric cancer research cooperative, with over 200 facilities and 5,000 specialist 
physicians (O’Leary, Krailo, Anderson, & Reaman, 2008). In a meta-analysis of pediatric 
ALL survival, children treated at COG institutions were consistently found to have 
significant survival advantage compared to children treated at facilities that are not 
associated with COG membership (Bhatia, 2011). 
During the time period examined in this study for ALL diagnosis (1995-2009), 
COG facilities were located within eight major metropolitan areas covering east, west, 
north, and central Texas, including the Panhandle area. The metropolitan areas of 
Dallas/Fort Worth, San Antonio and Houston were all home to two COG facilities. No 
COG facilities were located within the entire 32-county Texas-Mexico border area in 
southern Texas (Cure Search, 2009). Travel of hundreds of miles would be required by 
south Texas residents to reach any Texas COG facility. This is also true of any COG 
facilities located in adjoining states of New Mexico, Oklahoma, Arkansas, and Louisiana. 
3 
 
Figure 1 illustrates the 32-county Texas-Mexico border region and the locations of COG 
facilities within the state of Texas. 
 
Figure 1. The Texas-Mexico border area and COG facility locations.  
 
Problem Statement 
Despite continued advances in diagnostics and treatment protocols which have 
resulted in increased survival, cancer remains the leading cause of disease-related 
mortality in children and the second leading cause of death overall (American Cancer 
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Society, 2016). A large area of the Texas population does not have access to COG 
facilities. The Texas-Mexico border region of the state is particularly isolated from the 
advanced care provided by pediatric oncology research centers. As discussed in Chapter 
2, a lack of literature exists on access to care disparities in children. This population may 
be medically underserved resulting in tragic and needless loss of life from a curable 
disease. 
Researchers have consistently shown that the type of facility administering care to 
children diagnosed with ALL to be associated with survival (Bhatia, 2011; Hunger et al., 
2012). During the study period (1995-2009) the Texas-Mexico border area was void of 
COG institutions that offer the best treatment regimens available for ALL. 
The population of this area is primarily Hispanic and poor (U.S. Census Bureau, 
2013). Researchers have repeatedly shown that both opportunity and cultural factors 
result in the underrepresentation of minorities in clinical trials, the gold standard for 
improved cancer treatments and survival (Ford et al., 2008). The multiple factors of 
geographic isolation, poverty, and ethnicity pose a high risk in seeking treatment at more 
local non-COG affiliated facilities, and thus poorer survival in the Texas-Mexico border 
area. 
Purpose of the Study 
The purpose of this quantitative study was to examine the survival of children in 
Texas diagnosed with ALL in regards to the facility of treatment, poverty status, gender, 
race/ethnicity, and geographic location. Of additional interest was to document survival 
of those children residing in the Texas-Mexico border region. There are no current 
5 
 
published statistics for ALL specific to the Texas-Mexico border area. These data were 
compared to the nonborder area of the state to identify possible disparities in survival of 
the disease. A more thorough discussion of the variables examined and analyses is 
covered in Chapter 3. 
Research Questions and Hypotheses 
The research questions reflect the need to examine survival of ALL in Texas in 
more detail. The study seeks to examine several important questions: 
1. What are the descriptive epidemiology statistics of childhood ALL in Texas? 
These statistics will include ALL incidence, mortality, and survival rates for 
children 0-14 years of age residing in Texas diagnosed 1995-2009. 
2. Is there an association between COG facility affiliation and 5-year survival of 
ALL? 
Ho2: COG facility affiliation has no effect on 5-year survival of ALL. 
Ha2: COG facility affiliation has an effect on 5-year survival of ALL. 
3. Is there an association between COG facility affiliation and 5-year survival of 
ALL controlling for race, place of residence, and poverty?  
Ho3: There is no association between facility affiliation and 5-year survival of 
ALL when controlling for race, place of residence, and poverty. 
Ha3: There is an association between facility affiliation and 5-year survival of 
ALL when controlling for race, place of residence, and poverty.  
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Results will increase understanding of the burden of ALL in Texas, including the 
expansive Texas-Mexico border area and identify specific target areas for further study 
and public health interventions. 
Theoretical Foundation 
This study will use Krieger’s model of ecosocial theory, which poses as its main 
question “who and what is responsible for population patterns of health, disease, and 
wellbeing” and addresses social inequalities in health (Krieger, 2001; Krieger, 2002). The 
researcher theorizes that geographical isolation as a barrier to the best risk-based 
treatment is more a factor in pediatric ALL survival than poverty or Hispanic ethnicity.  
This ecosocial theory of health encompasses more than the traditional theories in 
epidemiology and disease, many of which focus primarily on the occurrence of disease 
and causation.  Krieger (2013) combines the social and ecological aspects of population 
health, including physical environment, with more traditional epidemiologic theory. 
Ecosocial theory examines the relationships between biological, social, political, and 
economic aspects of population patterns of not only disease, but well-being (Krieger, 
2001). One of the theory constructs stresses the role of discrimination and health 
inequalities created by social systems that contribute to both disease and outcomes. The 
result is a more complete epidemiological approach that may also be used to examine and 
explain disease survival.  
Further, Krieger (2013) argues that it is the also the obligation of epidemiologists 
and researchers to become activists against injustice when such health disparities due to 
social constructs are identified. Social change is a key construct to healthier populations.  
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Rationale for the Research 
Studies addressing racial/ethnic health disparities in children are few compared to 
their adult counterparts (Flores, 2010). Limited data also exists on Hispanic children 
diagnosed with ALL. The large Hispanic population of Texas including the 
predominantly Hispanic population of the expansive Texas-Mexico border area presents 
an opportunity to contribute to these areas of study and expand the literature available. 
Pediatric cancers are much less common than the disease in adults. In addition, 
pediatric cancers are unique in outcomes research in that the behaviors and actions of 
others (parents) instead of the individual are a predominant factor in treatment and 
survival. As a result pediatric studies are greatly lacking in the literature. 
Using 1988-2008 SEER data, Goggins and Lo (2012) found poorer survival for 
Black, Hispanic, Asian, and American Indian/Alaskan Native (AIAN) children diagnosed 
with ALL when compared to non-Hispanic Whites. In an analysis of both SEER data and 
cooperative group clinical trials, Bhatia (2011) reported higher mortality in both 
Hispanics and Blacks, even when controlling for biological factors associated with poorer 
outcomes. 
In contrast, studies by Pui et al. (2003, 2012) at St. Jude Children’s Research 
Hospital consistently found that with equal therapy, outcomes were the same for all 
children, regardless of race. The authors suggested reported race/ethnicity health 
disparities in the treatment of ALL are due to unequal healthcare access and differences 
in treatment protocols. It is of note that the St. Jude studies only used White and Black 
race categories, without regards to Hispanic ethnicity.  
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For children who do not have access to these specialty facilities, advanced 
treatment protocols, and quality followup care, the question of equal treatment/outcomes 
is a moot point. O’Leary et al. (2008) reported that 90-95% of children in the United 
States aged 0-14 years diagnosed with cancer are seen at a COG facility. To date, only 
one state-based study assessing overall COG facility affiliation has been completed, with 
87% participation reported in Georgia (Howell, Ward, Austin, Young, & Woods, 2007). 
Nature of the Study 
This population-based quantitative study used a retrospective cohort design 
utilizing secondary data. This type of study is well-suited for population-based cancer 
epidemiological studies, especially for rarer neoplasms. State cancer registries and/or 
Surveillance, Epidemiology, and End Results (SEER) data are sources of secondary data 
for many such population studies. This study compared groups of children in Texas 
diagnosed with ALL in terms of survival and the association with the type of facility 
administering care, geographic area of residence, race/ethnicity, gender, and poverty 
status. All data are secondary, having been previously collected by the Texas Department 
of State Health Services through the Texas Cancer Registry (TCR), who mandated by 
state law maintain a registry of all incidence cases. Appropriate rates, chi-square, and 
logistic regression analyses were conducted. More detailed discussions of study 




Acute lymphoblastic leukemia (ALL): The most common cancer in children 
characterized by the abnormal production of immature lymphocytes, a specific type of 
white blood cell, in the bone marrow and blood stream (Pui, 2012). 
 Children’s Oncology Group (COG) facility: One of 12 member-affiliated 
pediatric oncology specialty centers located within the state of Texas. The defining factor 
of these facilities is pediatric cancer research including clinical trials (COG, 2016). 
 Risk-based treatment: Treatment based on a comprehensive diagnostic profile that 
considers several clinical and biological factors, including advanced morphology, 
immunology, genetics, and molecular laboratory analyses. This difficult process requires 
the most advanced technology and trained personnel, and thus is very expensive (Carroll 
et al., 2003). 
 Texas Cancer Registry (TCR): A statewide population-based registry in Texas that 
collects cancer incidence and mortality data per state mandated law (TCR, 2014). The 
registry meets all standards set forth by the National Program of Central Cancer 
Registries of the Centers for Disease Control. Data from the TCR have the highest quality 
certification from the North American Association of Central Cancer Registries (TCR, 
2014).  
 Abstract report: The original document submitted to the Texas Department of 
State Health Services/TCR from a healthcare facility reporting a case of ALL or other 
cancer. Per state law, a facility is required to file a report for any patient seen with cancer, 
even if the patient was diagnosed/treated prior at another facility (TCR, 2014). As a 
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result, a report should be received from every facility each cancer patient visits, 
regardless of the reason/condition for admission.  
Assumptions 
While the incidence data required for this study from TCR were subjected to 
rigorous quality assurance protocols and have achieved high national standards, the 
chance for miscoding and other inaccuracies exists. Data are assumed to reflect actual 
ALL cases and other coding as to age and address at time of diagnosis correct. Facility 
identification and address from the reports is assumed accurate and was used only to 
indicate that the patient was seen at that facility. No followup was made to confirm or 
refute any data element. 
Scope and Delimitations 
Cancer data collection at TCR is passive, relying on reports from healthcare 
facilities throughout the state, including hospitals, cancer treatment centers, and 
pathology laboratories. Cancer is a reportable condition to the state health department per 
Texas state law, with reports required to be sent to TCR within 6 months of initial 
diagnosis or admission (TCR, 2014). Vital status and date of death are contained in these 
reports and included in the incidence database. The scope of this study was limited to 
ALL diagnosed among children residing in the state of Texas. Further comparisons 
between state and national populations are common in cancer epidemiology studies.     
Cancer incidence reports in this study were limited to the following: 
1. Reports must have a diagnosis date falling between January 1, 1995 and 
December 31, 2009. 
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2. Patient must be recorded as a resident of the state of Texas at the time of 
diagnosis. 
3. Patient must be less than 15 years of age at the time of diagnosis. 
Limitations 
The exact reasons as to why an individual did not visit a COG facility cannot be 
determined from this study. Given all COG facilities provide care regardless of inability 
to pay along with multiple financial and transport support resources (Cure Search, 2009) 
physical access to such facilities must be considered. Support services are also provided 
in Spanish and include local providers. Given the citizenship status of many residents 
along the Texas-Mexico border, this must also be considered in seeking care from 
institutions located long distances from resident communities.     
 The possibility exists that facilities did not file cancer reports with the TCR. This 
could result in an incomplete assessment of patient care. However, COG facilities not 
only maintain a cancer registry for reporting per state law but also to meet criteria for 
membership in the COG research collaborative. COG facilities not reporting should be 
minimal and possibly even nonexistent. 
The possibility exists that cancer patients may obtain care at a COG facility in 
another state. However, given the location of the Texas border area and the highly-rated 
and professionally respected facilities within the state, this would probably be a rare 
occurrence. When considering COG facilities, the locations in neighboring states are 
even further from in-state locations. This further illustrates the geographic isolation of 
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this area from pediatric oncology research facilities. Visits to out-of-state facilities were 
noted in the analyses.   
 Most Hispanic children in Texas reside in the border area, and populations of non-
Hispanic Whites and other races are extremely low. As childhood cancer is an uncommon 
condition compared to adult cancers, many other areas of the state will not have the 
population size to produce the case counts needed to calculate stable incidence and 
mortality rates. Only the Dallas/Fort Worth and Houston metropolitan areas contain a 
Hispanic population large enough for comparison to areas located within the border area. 
As a result this study was limited to comparing Hispanic children in the Texas border 
area to Hispanics and non-Hispanic Whites residing in the collective nonborder counties 
of Texas. It is of note there were four COG facilities in the Dallas/Fort Worth and 
Houston metropolitan areas during the study period. 
 Life tables representing the survival of the general United States 
population are used in calculation of relative survival. The life tables are used in 
substitution of a cancer-free cohort for comparison to observed survival of cohorts of 
individuals diagnosed with cancer. This methodology provides measures for comparing 
survival between groups defined by variables such as race/ethnicity, and is currently used 
in NCI/SEER statistical publications (Howlader et al., 2016). However, at the time of this 
research specific life tables for Hispanics were not available. As a result, relative 5-year 
survival was only calculated for all races combined. 
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The question of actual treatment, if any and the extent of any treatment protocols 
were not assessed and out of the scope of this study. Howell et al. (2007) and O’Leary et 
al. (2008) only examined documented facility visits and not actual treatment. 
Significance of the Study 
Not all children in the United States have benefited from the advances in 
treatment and increased survival of ALL. This has proven especially true for minority 
children and children from low SES families. However, many of those cancer studies 
used data provided by the Surveillance, Epidemiology, and End Results (SEER) program 
of the National Cancer Institute (NCI). This program consists of 18 state and city cancer 
registries, representing 26% of the United States population (SEER, 2009). Jamal, Siegel, 
Xu, and Ward (2010) published United States childhood cancer survival statistics using 
only SEER data. Siegel et al. (2012) reported 91% survival for ALL cases diagnosed 
2001-2007 using only a SEER dataset.  
The state of Texas is not currently included in the SEER program. This study 
offers a unique opportunity to examine ALL among a large and unique population of 
Hispanic children and identify potential health disparities. The large geographic layout of 
the state, larger than many European countries, provides the opportunity for unique 
geospacial comparisons. This study utilizing 15 years of data created a substantial 




Significance to Social Change 
It was estimated that in 2016 over 1.6 million new cases of invasive cancer would 
be diagnosed in the United States with over 595,000 deaths from the disease, an average 
of almost 1,600 per day (ACS, 2016). Cancer is only surpassed by heart disease in the 
United States as the overall leading cause of death (Jemal, Siegel, Xu, & Ward, 2010). 
This gap has narrowed substantially over recent years, and since 1999 cancer has become 
and remains the leading cause of death for people younger than age 85 years (Jemal et al., 
2010).  
 Children also die of cancer, and some of treatable and survivable malignancies 
such as ALL. When examined in further detail, many of these children are found to have 
similar demographic characteristics associated with mortality.  The goal of this study was 
to further identify such health disparities, and reveal the needless suffering and death of 
children living in the United States.   
The debate exists whether healthcare is a privilege or a right. Opinions have 
changed over the years, and the Patient Protection and Affordable Care Act of 2010 
allowed many access to healthcare that previously were without health coverage. 
However, many states including Texas refused to implement the policy. Due to politics, 
many Texas families still do not have health insurance coverage.  The health of the 
population should be a priority issue, especially for children. This study seeks to further 





Acute lymphoblastic leukemia (ALL) is the most common cancer in children, and 
one of the most treatable malignancies with some facilities reporting overall 5-year 
survival rates of 95% (Pui, Pei, et al., 2012).  Successful outcomes are influenced by 
several factors, including timely diagnosis, administration of proven effective risk-based 
treatment protocols, adherence to treatment, and continued followup. Access to such care 
can be limited by geographic location and SES. Researchers have had mixed results when 
examining race, ethnicity, and survival, and studies focusing on Hispanic children have 
been limited. In this study I seek to provide data from a unique population that has not 
been previously examined to contribute to this important area of study.    
This study examines the survival of children residing in Texas diagnosed with 
ALL 1995-2009. The purpose was to examine if COG membership holds prognostic 
significance on ALL survival. Large areas of Texas are isolated from COG facilities and 
residents must travel hundreds of miles to obtain expert pediatric oncology care. Such 
barriers have been associated with poorer cancer outcomes, including survival. 
Chapter 2 focuses on the complete background of ALL, a condition that 
physicians and researchers alive today remember was 100% fatal during their early 
careers. While great advances have been made in ALL survival, a significant number of 
children still die from the disease. Chapter 3 focuses on the data used in this study, study 
design, and the data analyses conducted. Chapter 4 reveals the results of the data analyses 




Chapter 2: Literature Review 
Introduction 
The purpose of this study was to examine if affiliation with Children’s Oncology 
Group (COG) facilities for treatment of childhood acute lymphoblastic leukemia (ALL) 
was associated with improved 5-year survival. These facilities offer the most 
comprehensive and effective treatments available administered by expert specialty 
physicians. Large areas of Texas are isolated from such facilities. It is the hypothesis of 
the author that this isolation creates an access to care barrier resulting in significant 
poorer survival. 
Several variables have been documented as having an association with poor ALL 
survival in children. These established predictors of ALL 5-year survival among children 
include facility-type associated with treatment, geographic area of residence, and 
residence-area poverty. State cancer registry data is commonly used in such studies. Kent 
et al. (2009) conducted a retrospective design study of childhood leukemia survival using 
cancer incidence data 1996-2005 from the California Cancer Registry. Howell et al. 
(2007) used data from the Georgia Cancer Registry 1998-2002 to examine COG 
participation among pediatric cancer patients residing in Georgia. Goggins and Lo (2012) 
used SEER data 1988-2008 to examine disparities among children diagnosed with ALL. 
Gutierrez, Cheung, Zhuge, Koniaris, and Sola (2010) used Florida cancer registry data to 
study COG efficacy in treating childhood malignancies. This quantitative retrospective 




Literature Search Strategy 
The primary search engine used in the literature review was PubMed, accessing 
primarily the MEDLINE database. Key search terms were "acute lymphocytic leukemia" 
and "Children's Oncology Group." Additional terms used were "survival," "childhood," 
"pediatric," "access to care," "treatment," and "health disparities." In addition several 
authors names were used who are considered experts in the field, such as Ching-Hon Pui, 
MD, and Smita Bhatia, MD, PhD.  
Several textbooks from the author's private collection were also used from both 
public health and clinical education and training. Additional texts and peer-reviewed 
journals from the Texas State Department of Health Services library were also used. 
Children's Oncology Group Facilities 
The specialty of pediatric oncology is a relative new area of medical expertise. 
The American Board of Pediatrics did not offer an examination for a subspecialty in 
hematology/oncology until 1974 (Wolff, 1991). According to Health Grades (2009), the 
nation’s leading independent health care rating organization, fewer than 2,000 pediatric 
oncologists/hematologists combined practice in the United States, with only 169 in the 
entire state of Texas.  Beginning in the 1950s, several groups were organized in the 
United States to focus on childhood cancer research. Over the next three decades these 
included the Cooperative Acute Leukemia Group A (CALGA) which soon became the 
Children’s Cancer Study Group (CCSG), the Southwest Oncology Group (SWOG), the 
Cooperative Acute Leukemia Group B (CALGB), the National Wilms Tumor Study 
Group (NWTSG), and others (Wolff, 1991). In 1986 several merged to form the Pediatric 
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Oncology Group (POG) eventually representing over 40 institutions. In 2000 all pediatric 
groups were merged into the Children's Oncology Group (COG), currently the world’s 
largest pediatric cancer research organization with over 200 member institutions 
conducting clinical trials (American Academy of Pediatrics, 2009). During the time 
period studied, 12 COG institutions were located within the state of Texas (Cure Search, 
2009). 
Nationally it is estimated that 90-95% of childhood cancer patients aged 0-14 
years are treated at COG facilities (O’Leary et al., 2008). However, analyzing 
Surveillance, Epidemiology, and End Results (SEER) data for pediatric cancer cases 
diagnosed 1992-1997 (N = 10,108) from 11 SEER registries, Liu, Krailo, Reaman, and 
Berstein (2003) found only 71% had been registered at a COG facility. As the TCR is not 
a SEER registry, Texas data were not included in the Liu et al. study. Carrol (2003) had 
reported previously over 80% of children will ALL in the United States would be treated 
at a COG facility.  
Researchers have repeatedly shown children with ALL treated at COG facilities 
had significant improved survival (Bhatia, 2011). St. Jude Children’s Research Center 
(2010) reported 94% 5-year survival for ALL and 77% for AML, well above published 
national survival rates. Texas Children’s Hospital (2010) reported increasing ALL 5-year 
survival in infants from 20% to 50% through clinical trials, with their developed therapy 
protocol becoming the national standard. The improved survival of ALL through clinical 
trial participation at pediatric oncology research centers has been documented as far back 
as 1983 (Meadows et al., 1983).  
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In a study of COG facility access in the state of Georgia, Howell et al. (2007) 
found 87% participation for children aged 0-14 years, with no disparity between Black 
and White children. For children diagnosed with ALL, 5-year survival was 86.3% for 
COG institutions and 53.3% for other facilities. No regional differences within the state 
were examined. This was in part due to the multiple COG facilities located in several 
states bordering Georgia. There were no areas within Georgia fully isolated from a COG 
pediatric oncology facility. 
This study used Texas population-based cancer data, collected directly by the 
state of Texas, and not a national database.  
Health Disparities 
Health disparities refer to differences in health, healthcare, and health outcomes 
based on personal demographic and socioeconomic factors (Bhatia, 2011). The U.S. 
Department of Health and Human Services (2000) targeted the elimination of health 
disparities as the second major public health objective to be achieved by the year 2010. 
These population-specific factors include race, ethnicity, socioeconomic status (SES), 
and geographic location. Health disparities are uniquely involved in childhood cancer in 
that these factors can apply to both the child diagnosed with cancer and parents seeking 
to provide care. Unfortunately, little improvement has been made in overall cancer health 
disparities despite decades of studies and public health interventions (Kagawa-Singer, 
Dadia, Yu, & Surbone, 2010).  
In a self-assessment of the goal of eliminating health disparities by 2010, the U.S. 
Department of Health and Human Services (2012) found that no state had achieved the 
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set goal of health insurance coverage, with Texas having the highest percentage of 
uninsured residents. More of the stated health objectives actually worsened (24%) than 
were achieved (23%), and was even more pronounced among Hispanics. In specific 
regards to health disparities, 80% of the targeted objectives remained unchanged. As a 
result, health disparities and basic healthcare access remained target goals for 
improvement by 2020. Even with these national targeted interventions, the literature for 
health disparity interventions addressing mortality and chronic disease in non-infant 
children remains severely limited (Flores, 2010).  
Race/Ethnicity 
 Hispanic children in the United States experience the highest incidence rate of 
ALL (ACS, 2012). Racial/ethnic minorities experience poorer cancer outcomes when 
compared to their White counterparts (Kagawa-Singer et al., 2010). Black, Hispanic, and 
American Indian/Alaskan Native (AIAN) children diagnosed with ALL have also been 
shown to have overall worse survival when compared to non-Hispanic Whites (Bhatia, 
2011).      
The mechanisms behind race/ethnicity and effect on ALL survival remain under 
investigation. Using population-based studies, Bhatia (2011) and Liu et al. (2003) 
reported that even with equal treatment Black, Hispanic, and AIAN children still 
experienced worse survival. In a followup examination, Goggins and Lo (2012) also 
reported poorer ALL survival for minorities when compared to non-Hispanic Whites 
using SEER data.  
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Examining cooperative group trial data 1990-2005, Hunger et al. (2012) found 
poorer survival in Black and Hispanic children treated for ALL. Trend analyses 
conducted revealed that survival had increased for Black children 1990-2005, but 
decreased for Hispanics. The authors cite higher-risk biological factors (T-cell vs. B-cell 
origin) and genomic mutations at possible explanations.    
However, in institutional studies, Pui et al. (2003, 2012) found that with equal 
treatment, children of all races/ethnicities experienced the same outcomes, regardless of 
disease metrics at diagnosis. This would indicate that race/ethic differences are more 
associated with variances in complete administered treatment protocols.  
Socioeconomic Status 
 Socioeconomic status (SES) plays a major role as a determinant in healthcare and 
health. The social stratification of individuals based on education, occupation, income, 
and residence in turn influences health status, access to care, and decisions about 
healthcare (Kagawa-Singer, Dadia, Yu, & Surbone, 2010). Later stage at diagnosis and 
less aggressive treatment have been identified as key risk factors in low SES groups 
(Byers et al., 2008). For many conditions, when SES factors are controlled disparities are 
greatly reduced or even eliminated. Social factors play a larger role than biologic factors 
in explaining racial/ethnic disparities (Byers et al., 2008).    
 Characteristics associated with SES have a substantial impact on both cancer 
incidence and mortality. For adult cancers, SES and poor outcomes can be in part 
attributed to lifestyle choices (tobacco use, diet, exercise, other behaviors, etc.) and 
nonuse of cancer screening. These factors are not as closely related to ALL and other 
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cancers in children. There are few identified lifestyle risk factors (parent or offspring) for 
childhood ALL and no screening protocols exist. 
Where prevention and early detection are mortality hallmarks of such adult 
neoplasms as prostate, cervical, colorectal, and breast cancer, ALL survival relies solely 
on precise timely diagnosis and treatment. The costs, time investment, and required 
resources between screening/prevention and treatment strategies are substantial. Even 
with comprehensive health insurance, associated out-of-pocket expenses such as 
copayments, travel, missed working hours or even employment termination resulting in 
lost income, and homecare expenses can be substantial (Bona et al., 2014). The poor 
suffer disproportionate financial losses, and costs associated with childhood cancer can 
cause families not in poverty to fall below the federal poverty level (Bona et al., 2014).    
 Comprehensive, optimal treatment for ALL involves repeated visits for two and 
often three years (Diller, 2011). Even under the most favorable financial conditions such 
a treatment protocol presents many challenges. Parsons (2006) reported that even with 
health insurance families with a child receiving treatment for ALL spent up to one-third 
of their after-tax income on related expenses. In 2007, 62% of all bankruptcies in the 
United States were caused by medical expenses, with 75% of those claims affirming 
having health insurance (Himmelstein, Thome, Warren, & Woolhandler, 2009). 
For poor families without health insurance the situation can be especially 
devastating both financially and psychologically. Even such basic needs as lack of 
nutritious food can have serious effects. Margolin et al. (2011) reported undernourished 
children diagnosed with ALL suffer 2.5 times the mortality from the disease. 
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The SES gradient, however, in childhood cancer is not always as linear as in adult 
cancers. In a study of California children diagnosed with ALL Kent et al. (2009) found 
that survival did not differ among SES levels for Hispanic children. The authors theorized 
that geographic location and access to the best care was a survival factor among Hispanic 
children in California.   
Geographic Location 
 The U.S. Department of Health and Human Services (2010) defined attaining 
adequate access to health care as being received timely, achieving the best results 
possible, and having three defined components: 
1. Gaining entry into the health care system. 
2. Getting access to sites of care where patients can receive needed services. 
3. Finding providers who meet the needs of individual patients and with whom 
patients can develop a relationship based on mutual communication and trust. 
(p.141) 
Children and their parents who live in geographically isolated areas are challenged to 
meet any or all of those criteria, especially those who are poor with language barriers and 
are in need of advanced specialty oncology care.  
Youlden et al. (2011) found that children diagnosed with cancer residing in 
remote areas of Australia had significantly lower survival compared to children living in 
cities. This was especially true for children diagnosed with ALL. Schillinger et al. (2011) 
found place of residence, and not poverty, was more significant in survival among 
children diagnosed with ALL in England.     
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Goodwin, Freeman, Mahnken, Freeman, and Nattinger (2002) used incidence, 
mortality, and survival to reveal geographic variations in breast cancer survival in the 
United States. Geographic variations in cancer survival have been identified in Europe, 
particularly when examining breast cancer (Sant et al., 2009). In both the American and 
European studies, variations in access to care, treatment protocols, adherence, and 
followup are viewed as likely reasons for these differences. In examining European 
Cancer Registry childhood cancer data, Gatta et al. (2005) found higher survival for 
lymphoid leukemia in Western Europe compared to Eastern Europe. Access to higher 
quality treatment was considered the reason for this discrepancy.     
 One geographically isolated area of the United States that has been studied is 
Appalachia, a mountainous region that stretches from New York down to the costal 
southern states. Characteristics of this area include poor health, poverty, and low 
education levels (Behringer et al., 2007). This region suffers from higher and premature 
mortality from many conditions including cancer (Wingo et al., 2008). The size and 
geographic isolation of many parts of the Appalachia area creates a distance to care 
barrier. High poverty and the unique cultural characteristics of the area create additional 
barriers to health care. 
 The Texas-Mexico border represents a very similar geographically isolated and 
culturally diverse region. In addition, over 5 million children in the United States have 
undocumented parents with over half living at twice below the federal poverty level 
(Urban Institute, 2010). This environment not only restricts access to quality care in the 
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United States, but forces many Texas residents to cross the Rio Grande and seek care and 
medications in the border towns of Mexico (Rivera, Ortiz, & Cardenas, 2009).   
At over 268,000 square miles Texas is physically the second largest state in the 
Union with 254 counties and a population of over 26 million, 27% of which are under the 
age of 18 years (U.S. Census Bureau, 2013). Texas is home to a large Hispanic 
population (38.2%), with the border area population 74.1% Hispanic (U.S. Census 
Bureau, 2013). 
The border counties of El Paso, Hidalgo, Cameron, and Webb are among Texas’s 
most populated, ranked 6th, 7th, 11th, and 21st respectively (U.S. Census Bureau, 2013). 
The border cities of El Paso, Brownsville, Laredo, and McAllen account for almost half 
the border area population, and are among the areas located furthest from COG facilities. 
Over 705,000 children below the age of 18 years reside in the Texas-Mexico border area 
(U.S. Census Bureau, 2013). 
In 2004, Texas Children’s Hospital, a COG facility in Houston, opened a satellite 
clinic in McAllen to provide some oncology services to children in south Texas. Clinical 
trials, the defining characteristic of COG membership, were not conducted during the 
study period. Clinical trials offer the latest innovative and most effective therapies 
available, and as a result children treated at these facilities have a significant survival 
advantage (Bhatia, 2011). Substantial progress and continued advances in childhood 
cancer treatment are the result of high-participation clinical trials at COG facilities 
(Siegel, Naishadham, & Jemal, 2012). Survival for ALL based on clinical trial strategies 
administered in COG facilities has collectively exceeded 90% (Robison, 2011).  
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As with much of Texas, a large portion of the border area is also rural. Rural areas 
have been identified as having higher poverty rates and increased health disparities 
(Eberhardt et al., 2001). Access to physicians in general can be a barrier to persons living 
in rural areas. Van Dis (2002) reported that while 20% of persons in the United States 
lived in rural areas, only 9% of the country’s physicians practiced in rural areas. The 
distribution of specialist physicians poses an even larger challenge.  
The predominantly Hispanic Texas border area is not only the poorest area of 
Texas, but one of the highest poverty areas of the United States (U.S. Census Bureau, 
2010). This is especially true for persons under 18 years of age. Over 37% of children 
residing in the 32-county border area were living in poverty in 2008 compared to 22.5% 
for the state and 18.2% for the United States (U.S. Census Bureau, 2010). 
McCarthy et al. (2009) reported that Texas ranks last in the nation for the number 
of children with health insurance. The largest concentration of these uninsured children 
occurs along the Texas-Mexico border (U.S. Census Bureau, 2010). The U.S. Census 
Bureau (2010) reported that for 2008 the population of the 32-county Texas-Mexico 
border area was 80% Hispanic, with some counties reporting over 95% persons of 
Hispanic origin. Researchers have shown that Hispanics are much more likely to be 
employed in occupations without employer-based benefits (Escarce & Kapur, 2006). 
The small communities in the border area known as "colonias" suffer from 
extreme poverty and poor health (Texas Secretary of State, 2014). These migrant 
neighborhoods are home to over 400,000 people and often lack the most basic of services 
and infrastructure including electricity, water, sewage, decent housing, and paved roads 
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(Texas Secretary of State, 2014). These areas are isolated from even the most basic 
medical and dental care.  
Literature Review of Pediatric ALL Epidemiology/Survival 
For the years 2007-2011, the overall incidence rate for ALL among children aged 
0-14 years in the United States was 4.2 per 100,000 population, with a mortality rate of 
0.3 per 100,000 (Howlader et al., 2014). While males experienced a slightly higher 
incidence rate than females, mortality rates were the same for both genders (Howlader et 
al., 2014). Males have been shown to have poorer outcomes (Kaden-Lottick et al., 2003; 
Hossain, Xie, & McCahan, 2014).  
Hispanic children experienced the highest incidence, and Blacks the highest 
mortality. Barrington-Trimis et al. (2015) reported that ALL incidence in Hispanic 
children was increasing at a statistically significant higher rate non-Hispanic children. 
Kaden-Lottick et al. (2003) reported poorer survival in Hispanic children when compared 
to non-Hispanics. However, as described earlier, all of SEER-based studies and many 
nationally published statistics do not include states/areas such as Texas with large 
Hispanic populations. 
Age at Diagnosis 
Age at diagnosis is a key prognostic factor in risk classification of ALL. Ages 1-4 
years of age experience the highest incidence and have the most favorable outcomes, with 
survival over 90% in the United States (Siegel, Naishadham, & Jemal, 2012). Infants 
younger than one year of age experience poor outcomes with 46% survival (Hossain et 
al., 2014). Survival of childhood ALL decreases with each additional year of age 
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beginning with diagnosis at 5 years of age, with survival decreasing to 57% for ages 15-
19 years (Hossain et. al., 2014). 
Importance of Risk-Based Treatment 
Four major types of leukemia are identified (Lichtman, 2008): 
1. Acute Lymphoblastic Leukemia (ALL) 
2. Acute Myeloid Leukemia (AML) 
3. Chronic Lymphoblastic Leukemia (CLL) 
4. Chronic Myeloid Leukemia (CML) 
The terms “acute” and “chronic” refer respectively to whether the progression of the 
disease is rapid or slow. The leukemia type is then designated by the blood cell type 
affected. Lymphoblastic leukemia refers to the uncontrolled proliferation of 
lymphoblasts, an immature type of white blood cell (Torpy, Lynm, & Glass, 2009). 
Myeloid leukemia is defined by the proliferation of cells other than lymphoblasts, such as 
other white blood cells, red blood cells, and platelets in the bone marrow (Altman & Fu, 
2011). Myeloid leukemia is rare in children and has a much poorer prognosis. The vast 
majority of childhood leukemia cases are acute - ALL and AML account for 
approximately 95% of all childhood leukemia cases (Onciu & Pui, 2012). Chronic 
leukemia in children is rare.  
ALL is further classified into subgroups based on the pathobiology of the 
leukemic lymphoblasts. The identification of the type of lymphoid cell from which the 
disease originates is of great importance and determined at diagnosis. Approximately 
85% of childhood ALL is of B-cell origin (Margolin, Rabin, Steuber, & Poplack, 2011). 
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Further classification based on cell morphology, immunology, cytogenetics, and 
molecular structure define the disease into even smaller sub-types. Detailed classification 
systems include the French-American-British (FAB) scheme and the World Health 
Organization (WHO) criteria (Onciu & Pui, 2012). With improved genetic analyses, these 
classifications continue to be expanded. 
Based on the multiple criteria of these systems, approximately 85% of children 
diagnosed with ALL are classified into the low risk category associated with the most 
favorable outcomes (Onciu & Pui, 2012). Basic criteria of this category include B-cell 
type disease diagnosed at 1-9 years of age, low leukocyte counts, and no testicular or 
CNS lesions (Pui, 2012). The detailed stratification of children into these risk groups has 
greatly improved the selection, administration, and effectiveness of treatment and 
subsequent survival (Seibel, 2008). Recent advances in molecular medicine, in particular 
pharmacogenomics which examines both patient and malignant leukemia cell genetic 
features, has shown great promise (Pui et al., 2008). Researchers continue to develop the 
most accurate risk categorization of ALL to administer the most effective treatments at 
the appropriate levels (Siebel, 2008).    
Treatment of ALL Protocols 
Unlike solid tumors where surgery or radiation can be specifically directed to a 
particular location, hematologic malignancies require a systemic approach. Solid tumors 
can often be detected and removed surgically at the early stages before the malignancy 
spreads which greatly improves the odds of successful treatment. Prior to the 1950s a 
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diagnosis of leukemia in a child was virtually a death sentence with zero treatment 
options available (Margolin et al., 2011).  
The selection of St. Jude, the patron saint of lost causes, in naming the now 
famous pediatric cancer research center in Memphis, Tennessee, directly reflected the 
general outlook in the early 1960s towards treating children with cancer. At that time a 
child diagnosed with ALL had less than 10% chance of survival (Hunger et al., 2012). As 
late as 1965 many medical experts were still publishing articles harshly criticizing 
research in childhood leukemia (Lichtman, 2008).     
With continued drug developments, improved multi-treatment components, and 
more focused risk-based treatment including cytogenetics, 10-year survival for ALL in 
children improved from 20% in the early 1970s to over 80% by 1995 (Margolin et al., 
2011). This is an important statistic as once 10-year survival is achieved the chance of 
relapse is very low. For low-risk categories of ALL treated with optimal protocols, 5-year 
survival progressed to exceed 90% (Pui et al., 2009). Many of the therapeutic agents 
initially identified and administered remain in present-day treatment protocols for ALL in 
children.  
Preventing Disease Relapse 
 Pui et al. (2008) reported that initial clinical remission, in which there is no 
physical or microscopic evidence of leukemia, could be achieved in 99% of children 
diagnosed with ALL. This first step in the treatment of ALL is known as the induction 
phase where the selected chemotherapy drugs and dose levels are administered over a 
period of several weeks (Margolin et al., 2011).  
31 
 
 Leukemic cells can often reside in the central nervous system (CNS) where some 
antileukemic drugs are not effective. It is imperative that during the induction phase no 
residual leukemic cells remain in the blood, bone marrow, or CNS. Physicians began 
using radiotherapy in the 1960s and 1970s to prevent CNS relapse in ALL cases, but this 
was later questioned due to the dangers of exposing a child’s brain and/or spinal cord to 
radiation (Margolin et al., 2011). Based on continued studies today most COG pediatric 
oncologists only advocate cranial radiation at diagnosis for the most high-risk ALL 
groups. With the improved success of risk-based chemotherapy, Pui et al. (2009) 
recommended eliminating radiotherapy completely in ALL treatment. Sophisticated and 
complex testing only available at pediatric oncology specialty facilities is needed to 
determine the risk/benefit ratio of various ALL treatments (Margolin et al., 2011)         
Late Effects of Treatment 
 The successful treatment of ALL with toxic anticancer agents created additional 
problems for researchers and clinicians to address, noted from the first clinical trials. The 
synthesis of less-toxic compounds improved side effects, but adverse conditions 
remained a problem.  Immunosupression was eventually successfully treated with 
antibiotics. Radiotherapy, used in the 1960s and 1970s to prevent CNS relapse in ALL 
cases, was later reserved for only the most high-risk categories due to the dangers of 
exposing a young child’s brain to radiation (Margolin et al., 2011).  
Oeffinger et al. (2006) found that childhood cancer survivors in general were 
more likely to have later diminished health status and die prematurely when compared to 
adults who were not diagnosed with cancer as a child. Two out of three childhood cancer 
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survivors developed complications due to therapy, with 25% of childhood cancer 
survivors developing a severe condition (Oeffinger et al., 2006) Survivors of ALL in 
particular are at risk for second neoplasms, neurological problems, cardiac dysfunction, 
infertility, and growth failure (Mody et al., 2008). Psychological and psychosocial 
problems, especially in individuals who received cranial radiation, are also of major 
concern in the ALL survivor (Zeltzer et al., 2009). Mertens (2007) reported significant 
mortality risk from treatment-related complications for up to 25 years after initial 
childhood diagnosis. 
Given the chance of relapse and the high incidence of associated late effects from 
ALL treatment, routine followup care is essential (Robison, 2011). The specific 
treatment-related risk factors of ALL must be continuously monitored for the earliest 
possible detection. As with initial evaluation and subsequent treatment, comprehensive 
risk-based care from the most skilled professionals in continued followup care is vital to 
long-term survival. Margolin et al. (2011) stressed that in addition to blood therapy and 
infection control, addressing nutritional needs and providing psychosocial support for the 
patient and family must also be included in any treatment protocol. Cultural issues must 
also be addressed (American Academy of Pediatrics, 2009). This comprehensive care 
must also be accessible. The American Academy of Pediatrics reported that many 
children diagnosed with cancer experience barriers, including having to travel long 




This chapter reviewed the treatment of pediatric ALL, and key factors associated 
with that treatment and survival. The successful treatment of ALL is one of the few major 
victories in treating children with cancer. Once 100% fatal, through research and 
technology survival in the United States has now exceeded 90%. Some COG facilities 
have even pushed survival of pediatric ALL to 95%.  
However, not all children in the United States have access to such expert care, and 
survival can vary due to several factors. Physicians and researchers at COG facilities 
have revealed that when treating the disease there are no clinical or biological factors that 
reduce survival with equal treatment. Even demographic factors such as gender, race, and 
ethnicity have no effect when the best risk-based treatments are applied. Thus, the 
reasons for poorer survival must be explained outside of the clinical environment. In 
order for children to experience the same level of survival, each child much be treated 
with the same level of care throughout their disease process available only at COG 
facilities. 
This study further examines the effectiveness of COG facility-affiliation in the 
treatment of pediatric ALL, and in a population previously not studied. Additional 
covariate variables were also examined. Chapter 3 describes the variables used in this 
research and the analyses conducted.   
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Chapter 3: Methodology 
Introduction 
The purpose of this study was to determine if facilities in Texas with COG 
membership offer prognostic significance in pediatric ALL survival. This chapter will 
discuss this study's design, study population, data collection, variables of interest, and 
data analyses. Quality assurance, confidentiality, and protection of human subjects are 
also addressed. 
Research Design and Rationale 
The design used for this study was a retrospective cohort design. This type of 
study is well-suited for population-based cancer epidemiological studies, especially for 
rarer neoplasms. State cancer registries and/or Surveillance, Epidemiology, and End 
Results (SEER) data are sources of secondary data for many such population studies. 
Data for this study was obtained from the Texas Cancer Registry (TCR). 
 This study was approved by the Walden University Institutional Review 
Board (IRB), approval number 11-04-16-0101571. As no confidential data elements were 
used in the analyses, no approval from the Texas Department of State Health Services 
(DSHS) IRB was needed. DSHS provides requested datasets for research from their 
available public-use list at no charge, requiring only a signed data use agreement. 
The study population for this study was all individuals residing in the state of 
Texas diagnosed with ALL 1995-2009 at age 14 years or younger. All incidence data 
used in this study was previously collected by TCR via passive surveillance through 
abstract reports, primarily from Texas hospitals and cancer treatment facilities. The 
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reports then must complete a series of quality assurance protocols to ensure high data 
quality before being accepted as a legitimate incidence case of cancer in Texas. By state 
law, TCR maintains a statewide cancer incidence database from these reports.  
In addition to specific cancer information, these reports include key fields for 
epidemiological study such as reporting facility, race/ethnicity, the address of residence 
at diagnosis, date of birth, date of diagnosis, vital status, and date of death (Table 1). TCR 
meets all standards of the Centers for Disease Control (CDC) National Program of 
Cancer Registries (NPCR) program, and is certified by the North American Association 
of Central Cancer Registries (NAACCR) for consistently achieving high data quality 
standards (TCR, 2010). 
The dependent variable in this study was 5-year survival. The independent 
variables were COG facility status (yes/no), geographic region of residence 
(border/nonborder), and poverty status (>= 20% for residents of county based on census 
tract data from U.S. Census Bureau). Galster (2012) found that most negative effects 
associated with poverty begin to manifest and progress rapidly once a neighborhood 









Table 1       
Study Variables 
Variable Type Coding Source   
Date of Birth Date MM/YYYY TCR   
Date of Death Date MM/YYYY TCR   
Gender Binomial Male/Female TCR   
Race/Ethnicity Categorical NHW,H,B,O* TCR   
Date of Diagnosis Date MM/YYYY TCR   
Age at Diagnosis Continuous 0-14 Years TCR   
Residence County Binomial Border/Nonborder TCR   
Vital Status Binomial Alive/Dead TCR   
COG Facility Binomial Yes/No TCR   
Poverty Status Binomial >=20% = Poverty U.S. Census   
*NHW=Non-Hispanic White, H=Hispanic, B=Black, O=Other 
To be included in the study, each reported incidence record must meet the 
following criteria: 
1. A diagnosis of ALL per the International Classification of Diseases for 
Oncology, 3rd edition (ICD-O-3).  
2. Diagnosed between the years 1995-2009. 
3. Diagnosed at age 14 years or younger. 
4. Resident of Texas at the time of diagnosis. 
5. No previously diagnosed malignant neoplasm. 
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No personal identifying information was requested or collected or used in any 
way in this study. No contact was or was made with any individual or medical personnel. 
All dates only include month and year for additional confidentiality. No individual case 
was identified with a specific facility, or any specific individual facility total case counts 
given.  
Wright (1995) recommended 50 cases per predictor variable to achieve 
appropriate statistical power in a logistic regression. Currently, there are 3,266 cases of 
ALL in the TCR database that meet the study inclusion criteria. This cohort size greatly 
exceeds the minimum required sample size to obtain accurate parameter estimates. In 
addition, to detect a small effect size (r2=.01) given the three independent variables at a 
statistical significance value of p < .01, Cohen (1992) calculated that 698 participants 
would provide 80% power in a multiple logistic regression. 
Research Methodology 
Research Questions 
1. What are the descriptive epidemiology statistics for childhood ALL in Texas? 
These statistics included ALL incidence, mortality, and relative 5-year 
survival rates for children 0-14 years of age residing in Texas diagnosed 1995-
2009. As of this writing there are no published epidemiological statistics of 
pediatric ALL specific to the Texas-Mexico border region. 
2. Is there an association between COG facility affiliation and 5-year survival of 
ALL? 
Ho2: COG facility affiliation has no effect on 5-year survival of ALL. 
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Ha2: COG facility affiliation has an effect on 5-year survival of ALL. 
3. Is there an association between COG facility affiliation and 5-year survival of 
ALL controlling for race, place of residence (border/nonborder), and poverty?  
Ho3: There is no association between COG facility affiliation and 5-year 
survival of ALL when controlling for race, place of residence, and poverty. 
Ha3: There is an association between COG facility affiliation and 5-year 
survival of ALL when controlling for race, place of residence and poverty.  
Data Analysis 
 After application and approval from the Texas Department of State Health 
Services, Texas Cancer Registry, ALL incidence data was provided in text file format for 
convenient import into multiple software packages. Descriptive statistics were calculated 
using SEER*Stat software from the National Cancer Institute (Table 2). Further analyses 
were performed using Statistical Analysis System (SAS), version 9.4. Correlations 
between binomial/categorical variables and COG affiliation were made using the chi-
square test (Table 3). These variables included gender, race/ethnicity, geographic region, 
and poverty status. Given at least three predictor variables of interest (facility affiliation, 
area of residence, poverty status) pending the chi-square tests, logistic regression was 
used to examine these variables in reference to the dependent variable of 5-year survival 
(Tables 4 and 5). Odds ratios with 95% confidence intervals were calculated to assess the 
strongest predictor(s) of survival. No censoring, loss to followup, or time to event 
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Association of Type of Facility with Demographic Variables 
Variable COG, N = Non-COG, N = X² P*  
Gender  
   Male 
     
   Female      
Race/Ethnicity      
   White      
   Black      
   Hispanic      
   Other      
Residence      
   Border      
   Nonborder      
Poverty      
   >= 20% 
   < 20% 
     
*P-value by chi-square for association between variables. 
The variables for the logistic regression analysis were:  
 Dependent Variable: 5-year survival, yes/no 
 Independent Variable: COG Facility, yes/no 
 Independent Variable: Residence, border/nonborder 






Logistic Regression with COG Facility 
 
Source B SE χ2 p OR 95% CI for OR 
       
COG Facility       
       
       
 
B: slope 
SE: standard error 
χ2: test statistic 
p: p-value 
OR: Odds ratio 




Logistic Regression with COG Facility, Residence, and Poverty 
 
Source B SE χ2 p OR 95% CI for OR 
       
COG Facility       
Residence 
Poverty 
      
       
 
B: slope 
SE: standard error 
χ2: test statistic 
p: p-value 
OR: Odds ratio 
95% CI for OR:  95 percent confidence interval for odds ratio 
 
Summary 
This chapter described the research methods to examine the survival of acute 
lymphoblastic leukemia (ALL) among children living in Texas. The author wishes to 
investigate the poorer survival of the disease among some children and if the type of 
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treatment facility is associated with 5-year survival. ALL is a very treatable condition in 
children and one of medicine's few major success stories against cancer. However, some 
children in Texas may not be receiving the best care available. No child should be at a 





















Chapter 4: Results 
Introduction 
The purpose of this quantitative retrospective epidemiologic study was to 
determine if facilities in Texas with Children's Oncology Group (COG) affiliation offer 
prognostic significance in pediatric acute lymphoblastic leukemia (ALL) survival. All 
data used is the study were previously collected by the Texas Cancer Registry (TCR). 
Texas law mandates that the state maintain a cancer registry. By Texas law cancer is a 
reportable condition to the state cancer registry. All hospitals and treatment centers are 
required to report each case diagnosed and/or treated. TCR is a member of the Centers for 
Disease Control (CDC) National Program of Cancer Registries and the North American 
Association of Central Cancer Registries (NAACR). 
Datasets with no personal health information are available from TCR to the public 
upon request. No personal health information was requested or used in this study. All 
counts, rates, and analyses were calculated at aggregate levels. The TCR data-use 
agreement requires that no aggregate data rates below the count of 16 individuals be 
presented.     
The initial selection criteria for the dataset was incident cases off ALL diagnosed 
during the years 1995-2009 among children less than 15 years of age residing in the state 
of Texas. This chapter first presents the descriptive epidemiological statistics of the study 






The variables used in this study were gender, race, ethnicity, diagnosis date, 
county of residence, reporting facility, vital status, date of death, poverty status, and five-
year survival. Poverty status was recorded from the United States Census Bureau based 
on the geocoded census tract of resident address. Poverty was defined as census tracts 
with > 20% poverty among residents. Five-year survival was defined as living at least 
five years from the date of diagnosis. Date of death indicates the date the individual died, 
or the date of last contact depending of the vital status being "alive" or "dead." The 
examined dataset had complete vital status followup through 2014, thus allowing for 
complete 5-year survival status of all included incident cases.  
Reporting facilities were dichotomized into two groups based on affiliation with 
the COG program. During the time of the study, COG member facilities were located in 
the metropolitan areas of Amarillo, Lubbock, Dallas/Fort Worth, Temple, Austin, San 
Antonio, Corpus Christi, and Houston. No COG facilities were located within the 32-
county border area. Border or nonborder county residence was based on the reported 
county of residence at the time of diagnosis. Race/ethnicity were combined into four 
groups of Non-Hispanic White, Black, Hispanic, and Other/Unknown.  
Based on the study selection criteria, 3,266 records of ALL were received from 
TCR. Incident counts for the variables of interest are given in Table 6. Of particular note 
was of the 482 cases of ALL from the 32-county border area, 417 (86.5%) cases were 






Variable Counts, Childhood ALL, Ages 0-14 Years, Texas, 1995-2009 
 
Variable n % 
   
Sex   
Male 1,795 55.0 
Female 1,471 45.0 
Race   
Hispanic 1,699 52.0 
Non-Hispanic Black 204 6.2 
Non-Hispanic White 1,225 37.5 
Other or Unknown 138 4.2 
Residence   
Nonborder 2,784 85.2 
Border 482 14.8 
Poverty status   
< 20% 2,125 65.1 
>20% 1,141 34.9 
Facility affiliation (COG)   
No 259 7.9 
Yes 3,007 92.1 
5-Year Survival of ALL   
No 453 13.9 
Yes 2,813 86.1 
Note. All percentages may not sum to 100 due to rounding error. 
 
 
Research Question 1 
What are the descriptive epidemiology statistics of childhood ALL in Texas? 
Using SEER*Stat software from the National Cancer Institute, the rates for incidence, 








Childhood Acute Lymphocytic Leukemia Rates, Texas, 1995-2009 
Residence Incidence Mortality 5-Year Survival   
Texas 4.2 0.4 86.3%   
Nonborder 4.1 0.3 87.8%   
Border 5.1 0.9 77.5%   
Note. All rates are per 100,000 and age-adjusted to the 2000 US Census Standard. 
 
The overall ALL incidence rate was 4.2 per 100,000 population for children ages 
0-14 years. The corresponding mortality rate for childhood ALL was 0.4 per 100,000 
population. The incidence rate of childhood ALL in the 32-county border region was 5.1 
per 100,000 population compared to 4.1 per 100,000 for the nonborder area of Texas. 
Border area Hispanics had an incidence rate of 5.4 compared to 5.2 for nonborder 
Hispanics. Childhood ALL mortality in the border area was 0.9 per 100,000 population 
compared to 0.3 per 100,000 for the nonborder area of the state. The mortality rate for 
border Hispanics was 0.9 compared to 0.5 for nonborder Hispanics.  
While five-year survival in Texas was consistent with national statistics at 86.3%, 
the 32-county border area was significantly lower for 5-year survival at 77.5%, and the 
nonborder area slightly higher at 87.8%. A 2x2 chi-square analysis revealed this 
difference was statistically significant, χ²(1) = 32.023, p < .001. In addition, the COG 
participation rate for the border area was 56.2% compared to 98.3% for the nonborder 
region of Texas.  
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Research Question 2 
Is there an association between facility affiliation and 5-year survival of ALL? 
Ho2: Facility affiliation has no effect on 5-year survival of ALL. 
 
Ha2: Facility affiliation has an effect on 5-year survival of ALL. 
 
A series of chi-square tests of independence were conducted to examine the relationships 
between sex, race, residence, poverty, and COG facility affiliation. The results are 



















Association of Type of Facility with Demographic Variables 
Variable COG, N = 3,007 Non-COG, N = 259 χ² p*  
Gender       0.05 .830  
   Male 1,651 (50.6%) 144 (4.4%)    
   Female 1,356 (41.5%) 115 (3.5%)    
Race/Ethnicity   120.18 <.001  
   White 1,190 (36.4%)   35 (1.1%)    
   Black    202 (6.2%)     2 (0.1%)    
   Hispanic 1,480 (45.3%) 219 (6.7%)    
   Other    135 (4.1%)     3 (0.1%)    
Residence   995.10 <.001  
   Border    271 (8.3%) 211 (6.5%)    
   Nonborder 2,736 (83.8%)   48 (1.4%)    
Poverty   144.55 <.001  
   >= 20%    962 (29.5%) 179 (5.4%)    
   < 20% 2,045 (62.6%)   80 (2.4%)    
      
*P-value by chi-square for association between variables. Note. All percentages may not 
sum to 100 due to rounding error. 
 
Of all variables examined, only sex was not statistically significant, suggesting 
sex and COG facility affiliation were not significantly associated with one another.  Race, 
residence, and poverty were all statistically significant, indicating a significant 
association with COG facility participation.  
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To address whether COG facility affiliation had an effect on 5-year survival of 
ALL, logistic regression was conducted. Logistic regression is an appropriate statistical 
analysis when assessing the predictive relationship between an independent variable and 
a dichotomous outcome variable. Facility affiliation was entered into the model as the 
predictor variable (1 = COG and 0 = Not COG).  The outcome variable corresponded to 
5-year survival of ALL (1 = Yes and 0 = No Survival). The results of the logistic 




Logistic Regression with COG Facility Affiliation Predicting Survival of ALL 
 
Source B SE Wald p OR 95% CI for OR 
       
COG Facility 0.07 0.18 0.15 .699 1.07 [0.75. 1.54] 
Note.  Overall model fit:  χ2(1) = 0.15, p = .699, Nagelkerke R2 < .001 
 
The results of the logistic regression were not statistically significant, χ²(1) = 0.15, 
p = .699, suggesting that COG facility affiliation alone was not significantly associated 
with 5-year survival of ALL.  As such, the null hypothesis cannot be rejected. Facility 
affiliation alone does not have an effect on 5-year survival. Statewide, there was not a 
statistically significant difference between patients being seen at COG-affiliated facilities 







Research Question 3 
Is there an association between COG facility affiliation and 5-year survival of 
ALL controlling for race, place of residence, and poverty? 
Ho3: There is no association between COG facility affiliation and 5-year survival 
of ALL when controlling for race, place of residence, and poverty. 
Ha3: There is an association between COG facility affiliation and 5-year survival 
of ALL when controlling for race, place of residence, and poverty.  
To address research question three, a logistic regression was conducted.  
Residence, poverty status, race, and COG facility affiliation were entered into the model 
as predictor variables.  Residence was treated as a dichotomous response, with 1 = border 
and 0 = nonborder.  Poverty status was treated as a dichotomous response, with 1 = 
poverty rate > 20% and 0 = poverty rate < 20%.  Facility affiliation was treated as a 
dichotomous response, with 1 = Yes (COG) and 0 = No (Non-COG).  Due to race being a 
categorical variable with four levels, the variable was dummy coded into three separate 
dichotomous variables for comparison.  During the dummy coding process, non-Hispanic 
White was treated as the reference group.  The outcome variable corresponded to 5-year 















Logistic Regression with COG Facility, Residence, Poverty, and Race 
 
Source B SE Wald p OR 95% CI for 
OR 
       
Residence -0.71 0.16 19.32 <.001 0.49 [0.36, 0.68] 
Poverty status -0.26 0.12 4.67 .031 0.77 [0.61, 0.98] 
Race (reference: White)       
Hispanic  -0.18 0.13 2.00 .157 0.84 [0.65, 1.07] 
Black -0.36 0.21 2.91 .088 0.70 [0.46, 1.06] 
Other 0.57 0.36 2.56 .110 1.77 [0.88, 3.56] 
Facility affiliation -0.60 0.21 7.95 .005 0.55 [0.36, 0.83] 
Note.  Overall model fit:  χ2(6) = 55.17, p < .001, Nagelkerke R2 = .030 
 
The overall regression model was statistically significant, χ2(6) = 55.17, p < .001, 
suggesting that residence, poverty status, race, and facility affiliation have a significant 
collective effect on survival of ALL.  The regression coefficient for residence was 
significant, B = -0.71, p < .001, OR = 0.49, indicating that for individuals on the border, 
the odds of observing survival of ALL would decrease by approximately 49%.  The 
regression coefficient for poverty status was also significant, B = -0.26, p = .031, OR = 
0.77, indicating that for individuals in poverty areas, the odds of observing survival of 
ALL would decrease by approximately 77%.  None of the race coefficients were 
significant in the regression model.  The regression coefficient for facility affiliation was 
significant, B = -0.60, p = .005, OR = 0.55, suggesting that for participants with a COG 
facility affiliation, the odds of observing survival of ALL would decrease by 
approximately 55%.  Due to significance of the overall model and the individual 
predictor variables, the null hypothesis for research question three can be rejected.  There 
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was an association between COG facility affiliation and 5-year survival of childhood 
ALL when controlling for race, place of residence, and poverty. 
Multicollinearity can pose problems in regression models when intercorrelation 
among multiple predictor variables is moderate or high (Stevens, 2009). Highly 
correlated variables can result in inflated variances and unstable coefficient estimates. To 
further explore these results, Variance Inflation Factors (VIFs) were calculated to detect 
the presence of multicollinearity between the predictor variables. Variance Inflation 
Factors greater than 5 are cause for concern, whereas VIFs of 10 should be considered the 
maximum upper limit (Stevens, 2009). A score below 5 indicates little collinearity with 
the other variables (Stevens, 2009).  The VIF values for each dependent variable are 
presented in Table 11. 
 
Table 11 





Poverty Status 1.33 
Race (reference: non-Hispanic White)  
Hispanic  1.43 
Non-Hispanic Black 1.12 
Other 1.07 
Facility Affiliation 1.44 
 
All predictors in the regression model had VIFs less than 5, and thus there in no cause for 
concern of multicollinearity in the model. 
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 To further assess the significant predictor variables, chi-square analyses were 
conducted between residence and 5-year survival, and poverty and 5-year survival. The 
results are presented in Table 12. 
 
Table 12 
Association of Residence and Poverty with ALL 5-Year Survival 
Variable No Survival   
N = 453 
Survived              
N = 2,813 
χ² p*  
Residence   32.84 <.001  
   Border    346 (10.6%) 2,438 (74.6%)    
   Nonborder    107 (3.3%)    375 (11.5%)    
Poverty   25.70 <.001  
   < 20%    247 (7.6%) 1,878 (57.5%)    
   >= 20%    206 (6.3%)    935 (28.6%)    
*P-value by chi-square for association between variables. Note. All percentages may not 
sum to 100 due to rounding error. 
 
Residence and poverty were both statistically significant, indicating a significant 
association independently with childhood ALL 5-year survival. In addition, 2x2 chi-
square analysis between residence and poverty revealed a statistically significant 
association between the variables, χ²(1) = 535.39, p < .001.   
To further examine the issue of COG facility participation given the extreme rate 
difference between border (56.2%) and nonborder (98.3%) counties, a chi-square analysis 
was conducted using only border data. This analysis revealed a statistically significant 
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association between COG facility participation and childhood ALL 5-year survival,   
χ²(1) = 9.35, p = .002. This calculation also produced a statistically significant odds ratio 
of 2.0, 95% CI [1.3, 3.2]. While COG facility participation was not prognostic for 5-year 
survival statewide, COG facility participation was associated with increased survival for 
the 32-county border area.   
Summary 
The purpose of this study was to determine if facilities in Texas with COG facility 
membership affiliation offer prognostic significance in pediatric ALL survival. Incidence 
rates were consistent for Texas and the 32-county border and nonborder areas, and 
consistent with national statistics. Mortality was higher in the predominantly Hispanic 
border area while Hispanics in the nonborder area did not experience a significant 
mortality difference from Texas or national ALL mortality rates. 
Calculated 5-year survival rates revealed a statistically significant difference 
between survival in the 32-county border area and the collective nonborder region of 
Texas. In addition, the COG participation rate in the border area was 56%, far below the 
nonborder area rate of 98% and the national SEER rate of 95%. 
Descriptive statistics and chi-square tests of independence were used to examine 
trends in the nominal level variables.  The chi-square tests of independence determined 
that there was a significant relationship between race, residence, poverty status, and 
facility affiliation.  The results of the logistic regression analysis for research question 
two indicated that there was not a significant predictive relationship between COG 
facility affiliation alone and survival of ALL statewide.  The null hypothesis for research 
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question two cannot be rejected.  The results of the logistic regression for research 
question three indicated that there was a collective predictive relationship between 
residence, poverty status, race, COG facility affiliation, and survival of pediatric ALL. In 
addition, three of the predictor variables, residence, poverty, and COG facility affiliation 
were individually statistically significant in the regression model. The null hypothesis for 
research question three can be rejected. 
To further assess the stability of the regression model, Variance Indicator Factors 
were calculated indicating no multicollinerarity between the predictor variables. 
Additional chi-square tests were conducted to further investigate the relationship between 
the significant predictor variables and childhood 5-year survival. An additional chi-
square test was conducted to examine the association of COG facility participation and 5-
year survival in the 32-county border area. While COG facility participation was not 
statistically significantly associated with 5-year survival statewide, the association was 
statistically significant for the border area alone.  
Chapter 5 will continue to discuss and interpret the findings of the data collection 
and analyses.  Connections will be made to the existing literature and theoretical 








Chapter 5: Discussion, Conclusions, and Recommendations 
Overview 
The purpose of this study was to determine if facilities in Texas with Children's 
Oncology Group (COG) affiliation offer prognostic significance in pediatric acute 
lymphoblastic leukemia (ALL) survival. Among children ages 0-14 years, leukemia is the 
most common malignancy with ALL accounting for 75% of those cases. While this 
disease predominates in children, it is also one of the most curable malignancies with 
expedient and proper diagnosis, treatment, and followup care. Pediatric oncology 
research centers are the hallmark of such care, especially those that have achieved COG 
membership.  
During the time period of this study, 1995-2009, Texas was home to 12 COG 
facilities located within eight metropolitan areas of the state. Those areas included the 
cities of Dallas, Fort Worth, Houston, San Antonio, Austin, Lubbock, Amarillo, Temple, 
and Corpus Christi. One area lacking a COG facility was the 32-county area of the Texas-
Mexico border. The Texas-Mexico border area is home to over 2.5 million people, with 
over 700,000 children and adolescents. Along with the extreme poverty of the area, this 
geographic isolation poses a significant barrier to the comprehensive and complex 
treatment needed to cure pediatric ALL. Health disparity studies among children are 
much fewer compared to adults, and geospatial studies extremely lacking.  
Race/ethnicity disparity studies among children diagnosed with ALL have been 
conflicting in regards to survival. Population-based studies using Surveillance, 
Epidemiology, and End Results (SEER) data from the National Cancer Institute have 
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revealed poorer survival for minorities. However, several facility-based studies have 
shown no differences in survival with equal treatment. Texas data is not included in the 
SEER dataset, and many studies examining racial disparities do not include Hispanics as 
a separate group. This study of children in Texas was unique in that 52% of the cases 
were recorded as Hispanic ethnicity. This was not surprising given Hispanics are the 
fastest growing population in Texas and ALL incidence is slightly higher in Hispanic 
children. A large Hispanic cohort along with the geospatial component and facility 
affiliation allowed for the examination of variables lacking in the literature. 
Summary of Findings 
  Incidence and mortality rates and 5-year survival were calculated for Texas, the 
32-county border area, and the nonborder area of the state. Childhood ALL incidence was 
consistent across Texas and both the border and nonborder areas, and consistent with 
national statistics. The overall statewide mortality rate of 0.4 per 100,000 population for 
childhood ALL in Texas was consistent with the United States rate of 0.3 per 100,000 
population (ACS, 2013) for the same time period. Hispanics in the border and nonborder 
area had similar incidence rates which were also consistent with national statistics. 
However, the mortality rate in in the predominantly Hispanic 32-county border area of 
0.9 per 100,000 population was three-times that of the mortality rate for the United 
States. Nonborder area Hispanics did not experience significant increased mortality. 
While 86.3% 5-year survival for childhood ALL in Texas was also consistent national 
statistics of 85% (Pui, Pei, et al., 2012), survival in the border area (77.5%) was 
statistically significantly lower when compared with the nonborder area (p < .001). 
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The overall Texas COG participation rate for childhood ALL was 92.0%, 
consistent with published studies using SEER data where over 90% of children under the 
age of 15 years with cancer were seen at a COG facility (Hunger et al., 2013). However, 
when examining the 32-county Texas-Mexico border area the COG participation rate for 
children diagnosed with ALL was 56.2% compared to 98.3% for the nonborder area of 
the state. The extremely low nonborder area COG participation rate surpasses any current 
published studies.     
Chi-square analyses were conducted comparing COG facility affiliation with the 
other independent variables of gender, race/ethnicity, area of residence, and poverty 
status. There was a statistically significant association (p < .001) between COG facility 
affiliation and race/ethnicity, area of residence, and poverty status. There was no 
association identified between COG facility affiliation and gender.   
While the COG participation rate for the border area was far below the rate for the 
nonborder area, COG facility affiliation alone was not a statistically significant predictor 
of 5-year survival. Logistic regression was performed using only COG facility affiliation 
as a dependent variable and 5-year survival as the outcome. As a result the null 
hypothesis of research question two cannot be rejected. There was no evidence that COG 
facility affiliation alone was associated with 5-year survival of childhood ALL statewide. 
   Logistic regression was then conducted adding race, residence, and poverty 
status to the model. The overall regression model was statistically significant (p < .001) 
suggesting that residence, poverty status, race, and COG facility affiliation had a 
significant collective effect on 5-year survival of childhood ALL. The coefficients for 
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residence, poverty status, and COG facility affiliation were all individually significant, 
while the coefficient for race/ethnicity was not. Race and Hispanic ethnicity were not 
statistically significant factors in ALL survival.  
Due to significance of the overall model and three individual predictor variables, 
the null hypothesis for research question was rejected.  There was an association between 
COG facility affiliation and 5-year survival of childhood ALL when controlling for race, 
place of residence, and poverty. 
It was surprising to find that overall in Texas, COG affiliation actually decreased 
the chance of 5-year survival. When examining the data, this result was due to the 
overwhelming 98.3% COG participation rate in the nonborder area of the state. In the 
United States, about 15% of children do not survive ALL (Pui, Pei, et al., 2012). Texas 
fared slightly better during the 1995-2009 time period at 86.3% 5-year survival. Most of 
those deaths occurred in the nonborder area of the state, and among individuals who had 
been seen at a COG facility. This paradox is discussed more thoroughly in the next 
section. 
To further assess the predictor variables in the regression model, chi-square was 
conducted between residence and survival, poverty status and survival, and residence and 
poverty status. All three associations were statistically significant (p < .001).  
Interpretation of Findings 
This study set out to investigate COG facility affiliation and 5-year survival of 
childhood ALL in Texas. Of particular interest was survival and COG utilization in the 
32-country Texas-Mexico border area, a known region of poverty and limited medical 
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resources. During the time of the study (1995-2009), no COG membership facilities were 
located within the 32-county border area, while the nonborder area of the state was home 
to 12 COG facilities.  
The 56.2% COG participation rate for the border area was far below the 98.3% 
participation rate for the nonborder area and 90-95% published participation rates for the 
United States. Chi-square revealed a statistically significant association between area of 
residence and COG facility affiliation (p < .001). In addition, childhood ALL mortality in 
the border area was three times that of the nonborder area of the state. Five-year survival 
was statistically significantly lower in the border area when compared the nonborder area 
of the state. The 77.5% 5-year survival rate in the border area would be comparable to 
United States figures from the 1970s. There was clearly a disparity in Texas for 
childhood ALL 5-year survival in the 32-county Texas-Mexico border area with just over 
half of children diagnosed being seen at a COG affiliated facility. 
However, COG facility membership alone did not explain the survival disparity. 
When examined individually, COG facility membership alone was not statistically 
significantly associated with 5-year survival of childhood ALL in Texas. Upon 
examining the data, the reason for this becomes clear.  
While the nonborder area of the state recorded 98.3% COG participation, 5-year 
survival was only 87.8%. Children diagnosed will ALL in this part of the state were 
visiting COG facilities but many did not achieve 5-year survival. The reasons for this 
cannot be determined from this study. But possible explanations are adherence to 
treatment regimens and following a complete treatment protocol with followup. This 
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study only examined if the child was at least seen at a COG facility. Others factors could 
include distance to care from rural areas, timely diagnosis, and unfavorable biological 
disease characteristics at time of diagnosis, such as T-cell ALL which has a poorer 
prognosis (Dores, Devesa, Curtis, Linet, & Morton, 2012). The vast majority of children 
diagnosed will ALL in the nonborder area were seen at a COG facility and thus the non-
COG comparison group was very small.  
In addition, while the 32-county border area only experienced 56.2% COG 
participation, many children did survive 5 years, although overall 5-year survival for the 
population was poor at 77.5%. While general ALL treatment protocols have been shown 
to be not as effective as individual risk-based designed protocols, standardized treatments 
can produce positive results. In 2004 Children's Hospital in Houston opened a satellite 
treatment clinic in the city of McAllen, located in Hidalgo County where 165 of the 
border area cases in this study were diagnosed. Adjacent Cameron County accounted for 
another 82 cases. This clinic may have proved beneficial for children diagnosed with 
ALL in that area. These types of clinics and "treatment sharing" have proved effective 
even in developing countries (Aristizabal et al., 2015). Such treatments may have also 
been used in the major hospitals in El Paso, where 131 of the cases were located. In 2015, 
facilities in both El Paso and McAllen received full COG membership affiliation. 
However, when border-only data were examined, COG facility participation not only 
becomes a statistically significant variable, but with a positive association towards 
survival. Children diagnosed with ALL residing in the 32-county border area seen at a 
COG facility were two-times more likely to survive than those not seen at a COG facility.   
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Overall, of the 453 cases of childhood ALL in Texas that did not achieve 5-year 
survival, only 38 were not seen at a COG facility. However, 33 of those non-COG 
affiliated deaths were cases from the 32-county border area. A much higher percentage 
(98.6%) of cases seen at a COG facility that did not achieve 5-year survival occurred in 
the nonborder area of the state. In the border area COG-affiliated cases only accounted 
for 69.2% of the cases that did not survive 5 years. While COG affiliation alone was not 
significant statewide when associated with childhood ALL 5-year survival, 30.8% of the 
cases that did not survive in the border area were not seen at a COG facility compared to 
1.4% for the nonborder area.    
In the final regression model, COG facility affiliation actually had a statistically 
significant but negative association with childhood ALL 5-year survival. Many children, 
even though seen at a COG facility, did not survive. In the United States 10-15% of 
children diagnosed with ALL do not survive (Pui, Pei, et al., 2012). In Texas for the years 
1995-2009, 13.7% of children diagnosed with ALL did not survive five years, yet 91.6% 
of those cases were seen at a COG facility. This high participation rate actually skews the 
association in a negative direction. The fact that poverty was a significant factor 
statewide in 5-year survival must be considered with this observation. One can only 
hypothesize what the survival rate would be without such high COG participation. 
Both region of residence (border, nonborder) and poverty status were statistically 
significantly associated with childhood ALL survival. Living in the border area and in 
poverty both decrease chances for survival. And unlike COG facility participation, these 
variables were both independently statistically significantly associated with childhood 
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ALL survival in chi-square analyses. Poverty and region of residence are stronger 
predictors of childhood ALL 5-year survival than COG facility affiliation statewide. The 
significant association between all three of those variables when combined sets the stage 
for a perfect storm. For children in Texas diagnosed with ALL residing in the 32-county 
Texas-Mexico border area, living in a neighborhood with high poverty, and not being 
seen at a COG facility, survival can be predicted to be much poorer. 
The major limitation of this study is there was no documentation of full treatment 
and followup. Full treatment of ALL can last up to three years. This study only 
documented children residing in Texas diagnosed with ALL being seen at least one time 
at a COG facility. Another limitation was that even with 15 years of data, only 3,266 
cases were collected. Pediatric ALL is a rare condition and multiple years of data are 
require to assemble even a small dataset. These data did reveal a major health disparity in 
the 32-county Texas-Mexico border area. The 77.5% ALL survival for the 32-county 
border area is consistent with national rates 40 years ago.      
Theoretical Basis of the Study 
Krieger's model of ecosocial theory (Krieger, 2001) was the theoretical basis of 
this study. The driving hypothesis behind this research was that geographical isolation as 
a barrier to the best risk-based treatment is more a factor in pediatric ALL survival than 
poverty or Hispanic ethnicity. Ecosocial theory examines the relationships between 
biological, social, political, and economic aspects of population patterns of not only 
disease, but well-being.  
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Analyses of Texas childhood ALL data 1995-2009 revealed no statistically 
significant association between gender or race/ethnicity and 5-year survival. Statewide 
poverty and area of residence were associated with poorer survival. Residing in the 
border area and living in a poor neighborhood were both predictors of poor survival. In 
addition, while not significant statewide, COG facility participation was significant in the 
border area and was associated with increased survival. These results describe an area of 
great health disparity due to social and economic factors. The poverty of the Texas-
Mexico border area and lack of access to the best and equal care were associated with 
poorer survival.  
Future Recommendations 
 This study examined ALL diagnosed among children ages 0-14 years residing in 
the state of Texas 1995-2009. A large health disparity was identified among children 
residing in the 32-county Texas-Mexico border region. These children experience poorer 
outcomes when compare to those who reside in the nonborder area of the state, resulting 
in mortality from a curable disease.  
 This study was limited in using population-based data previously collected from 
the Texas Cancer Registry. Further studies are needed to examine why so many children 
in the Texas-Mexico border region diagnosed with ALL are not receiving the best care 
possible. The vast distance distances to these facilities and available resources are no 
doubt factors. But other social factors such as trust and lack of education could also be 
involved in not seeking expert treatment. The thought of traveling with a very sick child 
to some of the largest cities in the country hundreds of miles from home is obviously an 
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extremely frightening situation. Even when these expert care facilities fully treat children 
with cancer regardless of a family's ability to pay, also including ancillary expenses such 
as lodging, travel, and food, many children do not get the best care available. 
 A more detailed geospatial study is needed to assess rural/urban differences and 
actual distances between residence and treatment facilities. Even in the nonborder region 
of the state, many rural counties are far away from major metropolitan areas. This could 
be achieved using geocoded data of residence and treatment facility.   
 In 2015 two facilities in the 32-county Texas-Mexico border region received 
COG membership. El Paso and McAllen, two of the largest populated areas of the region, 
now are home to a COG facility. Future studies are needed to examine the effect of these 
facilities on the poorer ALL survival of the region, and further interventions applied if 
necessary. Even with these two new COG designations, complete treatment and followup 
must occur for the best outcomes. As the data become available, 10-year survival studies 
need to be conducted to assess that a full cure was achieved. Not only is initial and 
expedient diagnosis critical and the best precise risk-based treatment applied, but that the 
full treatment protocol is diligently followed, including annual followup for 10 years.        
Implications for Social Change 
Acute lymphoblastic leukemia (ALL) is the most common cancer among children 
ages 0-14 years in the United States (Hunger et al., 2012). Fortunately it is also one of 
science's greatest triumphs against cancer, with 5-year survival exceeding 95% with the 
best treatments available (Pui, Pei, et al., 2012). Some facilities have even achieved the 
66 
 
cure standard of 10 years at 90% (Pui & Evans, 2013). Still, ALL remains the leading 
cause of cancer mortality in children less than 15 years of age. (Hunger et al., 2013).   
Unfortunately some children in the United States do not access and experience the 
care needed for such great achievements. This study has identified such a population. 
Children residing in the Texas-Mexico border area diagnosed 1995-2009 with ALL only 
achieved 77.5% 5-year survival. This study has the potential to promote positive social 
change in revealing such disparities, and hopefully increasing the understanding of 
childhood ALL and the need for expert, individual-based treatment. These data revealed 
that the reasons for poorer survival are associated with the social factors of poverty and 
access to care. Such social and cultural factors must be considered along with the latest 
evidence-based medicine for the best outcomes. 
Conclusion 
Prior to the 1960s a diagnosis of acute lymphoblastic leukemia (ALL) in a child 
was a literal death sentence. While men were walking on the moon, physicians and 
scientists were diligently trying to achieve a cure for the most common childhood cancer. 
Now in the United States 85.5% of children diagnosed with the horrible disease can be 
cured (Ma, Sun, & Sun, 2014). For the most advanced pediatric oncology research 
centers, 95% of children who receive full treatment and followup care are cured. Over 
200 of these facilities in the United States form the Children's Oncology Group (COG).  
Yet for many children in the United States, obtaining care at one of these facilities 
remains very difficult. This study has revealed such a population, and poorer survival of 
pediatric ALL among children 0-14 years of age. Almost half the children diagnosed with 
67 
 
ALL 1995-2009 who resided in the 32-county area along the Texas-Mexico border were 
not seen at pediatric oncology research center. This area is also plagued by high poverty 
rates, creating additional barriers to care. And while poverty occurs statewide in Texas, 
over 98% of children diagnosed with ALL in the nonborder region of the state were seen 
at a COG facility. Being predominantly Hispanic and a border area, cultural and social 
factors are involved, as well. For some children today, even with the advanced treatments 
available a diagnosis of ALL can still be a death sentence. Unlike many adult cancers 
where lifestyle changes and screening are associated with improved survival, accurate 
diagnosis and expedient treatment are the main factors involved with pediatric ALL 
survival. Inherited genetics, a hallmark risk factor in adult cancers, has only been 
associated with about 5% of pediatric ALL cases (Spector, Charbonneau, & Robison, 
2012). The best care available after diagnosis is the only plan for a child to survive the 
disease.  This must be considered as the United States struggles with how to deliver the 
best healthcare to its population, and who should or should not be a part of that 
population.  
In 1971 President Richard M. Nixon issued the ambitious challenge to cure a 
group of diseases that had longed plagued mankind. Just as President John F. Kennedy 
had declared to make travel to the moon a reality just 10 years prior, Nixon called on the 
best scientists and researchers in the country to conquer cancer (DeVita, 2002). Nixon 
later signed the National Cancer Act of 1971 which mandated eliminating the disease an 
issue of national importance (DeVita, 2002). The “War on Cancer” as it would be later 
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Appendix A: List of the 32 Texas-Mexico Border Counties 
Brewster 
Brooks 
Cameron 
Crockett 
Culberson 
Dimmit 
Duval 
Edwards 
El Paso 
Frio 
Hidalgo 
Hudspeth 
Jeff Davis 
Jim Hogg 
Kenedy 
Kinney 
La Salle 
McMullen 
Maverick 
Pecos 
Presidio 
Real 
Reeves 
Starr 
Sutton 
Terrell 
Uvalde 
Val Verde 
Webb 
Willacy 
Zapata 
Zavala 
 
